View in EDS

CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.

Saved in:
Bibliographic Details
Title: CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.
Authors: Neal J; Stanford Cancer Institute, Stanford University, Palo Alto, CA., Pavlakis N; Royal North Shore Hospital, University of Sydney, St Leonards, Australia., Kim SW; Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea., Goto Y; National Cancer Center, Tokyo, Japan., Lim SM; Yonsei University College of Medicine, Seoul, Republic of Korea., Mountzios G; Henry Dunant Hospital Center, Athens, Greece., Fountzilas E; Euromedica General Clinic of Thessaloniki, Thessaloniki, Greece., Mochalova A; MEDSI Clinic, Moscow, Russia., Christoph DC; Evang, Kliniken Essen-Mitte, Essen, Germany., Bearz A; CRO Aviano, National Cancer Institute, IRCCS, Aviano, Italy., Quantin X; Montpellier Cancer Institute, Inserm U1194, University of Montpellier, Montpellier, France., Palmero R; Catalan Institute of Oncology, Barcelona, Spain., Antic V; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Chun E; Genentech Inc, South San Francisco, CA., Edubilli TR; Roche Products Limited, Welwyn, United Kingdom., Lin YC; Genentech Inc, South San Francisco, CA., Huseni M; Genentech Inc, South San Francisco, CA., Ballinger M; Genentech Inc, South San Francisco, CA., Graupner V; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Curran D; Exelixis, Alameda, CA., Vervaet P; Exelixis, Alameda, CA., Newsom-Davis T; Chelsea and Westminster Hospital, London, United Kingdom.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jul 10; Vol. 42 (20), pp. 2393-2403. Date of Electronic Publication: 2024 Mar 29.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38552197
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Neal+J%22">Neal J</searchLink>; Stanford Cancer Institute, Stanford University, Palo Alto, CA.<br /><searchLink fieldCode="AU" term="%22Pavlakis+N%22">Pavlakis N</searchLink>; Royal North Shore Hospital, University of Sydney, St Leonards, Australia.<br /><searchLink fieldCode="AU" term="%22Kim+SW%22">Kim SW</searchLink>; Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Goto+Y%22">Goto Y</searchLink>; National Cancer Center, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Lim+SM%22">Lim SM</searchLink>; Yonsei University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Mountzios+G%22">Mountzios G</searchLink>; Henry Dunant Hospital Center, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Fountzilas+E%22">Fountzilas E</searchLink>; Euromedica General Clinic of Thessaloniki, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Mochalova+A%22">Mochalova A</searchLink>; MEDSI Clinic, Moscow, Russia.<br /><searchLink fieldCode="AU" term="%22Christoph+DC%22">Christoph DC</searchLink>; Evang, Kliniken Essen-Mitte, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Bearz+A%22">Bearz A</searchLink>; CRO Aviano, National Cancer Institute, IRCCS, Aviano, Italy.<br /><searchLink fieldCode="AU" term="%22Quantin+X%22">Quantin X</searchLink>; Montpellier Cancer Institute, Inserm U1194, University of Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Palmero+R%22">Palmero R</searchLink>; Catalan Institute of Oncology, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Antic+V%22">Antic V</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Chun+E%22">Chun E</searchLink>; Genentech Inc, South San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Edubilli+TR%22">Edubilli TR</searchLink>; Roche Products Limited, Welwyn, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lin+YC%22">Lin YC</searchLink>; Genentech Inc, South San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Huseni+M%22">Huseni M</searchLink>; Genentech Inc, South San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Ballinger+M%22">Ballinger M</searchLink>; Genentech Inc, South San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Graupner+V%22">Graupner V</searchLink>; F. Hoffmann-La Roche Ltd, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Curran+D%22">Curran D</searchLink>; Exelixis, Alameda, CA.<br /><searchLink fieldCode="AU" term="%22Vervaet+P%22">Vervaet P</searchLink>; Exelixis, Alameda, CA.<br /><searchLink fieldCode="AU" term="%22Newsom-Davis+T%22">Newsom-Davis T</searchLink>; Chelsea and Westminster Hospital, London, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2024 Jul 10; Vol. 42 (20), pp. 2393-2403. <i>Date of Electronic Publication: </i>2024 Mar 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38552197
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO.23.02166
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2393
    Titles:
      – TitleFull: CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Neal J
      – PersonEntity:
          Name:
            NameFull: Pavlakis N
      – PersonEntity:
          Name:
            NameFull: Kim SW
      – PersonEntity:
          Name:
            NameFull: Goto Y
      – PersonEntity:
          Name:
            NameFull: Lim SM
      – PersonEntity:
          Name:
            NameFull: Mountzios G
      – PersonEntity:
          Name:
            NameFull: Fountzilas E
      – PersonEntity:
          Name:
            NameFull: Mochalova A
      – PersonEntity:
          Name:
            NameFull: Christoph DC
      – PersonEntity:
          Name:
            NameFull: Bearz A
      – PersonEntity:
          Name:
            NameFull: Quantin X
      – PersonEntity:
          Name:
            NameFull: Palmero R
      – PersonEntity:
          Name:
            NameFull: Antic V
      – PersonEntity:
          Name:
            NameFull: Chun E
      – PersonEntity:
          Name:
            NameFull: Edubilli TR
      – PersonEntity:
          Name:
            NameFull: Lin YC
      – PersonEntity:
          Name:
            NameFull: Huseni M
      – PersonEntity:
          Name:
            NameFull: Ballinger M
      – PersonEntity:
          Name:
            NameFull: Graupner V
      – PersonEntity:
          Name:
            NameFull: Curran D
      – PersonEntity:
          Name:
            NameFull: Vervaet P
      – PersonEntity:
          Name:
            NameFull: Newsom-Davis T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 07
              Text: 2024 Jul 10
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 20
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1